Jialin Luo

700 total citations
30 papers, 534 citations indexed

About

Jialin Luo is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Jialin Luo has authored 30 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Jialin Luo's work include Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Jialin Luo is often cited by papers focused on Colorectal Cancer Surgical Treatments (6 papers), Colorectal and Anal Carcinomas (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Jialin Luo collaborates with scholars based in China and United States. Jialin Luo's co-authors include Yuan Zhu, Luying Liu, Yu Mi, Ping Liu, Jie He, Xiaohan Yu, Hongyan Ge, Yang Yang, Ke Lü and Na Zhang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Gene.

In The Last Decade

Jialin Luo

30 papers receiving 530 citations

Peers

Jialin Luo
Emily Harris United States
Rong Zheng China
Patrycja Sosińska Poland
Xianwen Zhao China
Lan Liu China
Zixuan Yang China
Lihua Huang China
Emily Harris United States
Jialin Luo
Citations per year, relative to Jialin Luo Jialin Luo (= 1×) peers Emily Harris

Countries citing papers authored by Jialin Luo

Since Specialization
Citations

This map shows the geographic impact of Jialin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialin Luo more than expected).

Fields of papers citing papers by Jialin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialin Luo. The network helps show where Jialin Luo may publish in the future.

Co-authorship network of co-authors of Jialin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jialin Luo. A scholar is included among the top collaborators of Jialin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialin Luo. Jialin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Shu, Jialin Luo, Haoyuan Wang, et al.. (2023). Development and validation of a prognostic nomogram for gastrointestinal stromal tumors in the postimatinib era: A study based on the SEER database and a Chinese cohort. Cancer Medicine. 12(15). 15970–15982. 2 indexed citations
3.
Wang, Shu, Mengbin Li, Jiyang Zheng, et al.. (2023). M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study. Frontiers in Oncology. 13. 1139990–1139990. 10 indexed citations
4.
5.
Feng, Yanru, Jialin Luo, Luying Liu, et al.. (2022). Glasgow prognostic score and combined positive score for locally advanced rectal cancer. Annals of Surgical Treatment and Research. 102(3). 153–153. 4 indexed citations
6.
7.
Feng, Yanru, Jialin Luo, Peng Liu, et al.. (2022). Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer. Discover Oncology. 13(1). 10–10. 1 indexed citations
8.
Yang, Jing, Jiali Wang, & Jialin Luo. (2019). Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib. Pathology - Research and Practice. 215(10). 152565–152565. 11 indexed citations
9.
Sun, Quanquan, Tongxin Liu, Peng Liu, et al.. (2019). Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery. Journal of Cancer. 10(10). 2243–2249. 46 indexed citations
10.
Luo, Jialin, Luying Liu, Ning Zhou, et al.. (2018). miR-519b-3p promotes responsiveness to preoperative chemoradiotherapy in rectal cancer patients by targeting ARID4B. Gene. 655. 84–90. 17 indexed citations
11.
12.
Luo, Jialin, Caineng Cao, Yuan Zhu, et al.. (2016). Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma. OncoTargets and Therapy. Volume 9. 6147–6150. 2 indexed citations
13.
Zhang, Na, Caineng Cao, Yuan Zhu, et al.. (2016). Primary breast diffuse large B-cell lymphoma in the era of rituximab. OncoTargets and Therapy. Volume 9. 6093–6097. 10 indexed citations
14.
Zhang, Na, Caineng Cao, Yuan Zhu, et al.. (2016). Primary breast lymphoma: A single center study. Oncology Letters. 13(2). 1014–1018. 19 indexed citations
15.
Jin, Ting, Yuan Zhu, Jialin Luo, et al.. (2015). Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer. International Journal of Colorectal Disease. 30(3). 337–345. 13 indexed citations
16.
Liu, Luying, Caineng Cao, Yuan Zhu, et al.. (2015). Preoperative chemoradiotherapy with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer: long-term results of a phase II trial. Medical Oncology. 32(3). 70–70. 6 indexed citations
17.
Xu, Jingyue, Ying Li, Yanjun Huang, et al.. (2015). A facile aptamer-based sensing strategy for dopamine through the fluorescence resonance energy transfer between rhodamine B and gold nanoparticles. Dyes and Pigments. 123. 55–63. 49 indexed citations
18.
Yang, Yang, Jialin Luo, Xiaoming Zhaı, et al.. (2014). Prognostic value of phospho‐Akt in patients with non‐small cell lung carcinoma: A meta‐analysis. International Journal of Cancer. 135(6). 1417–1424. 22 indexed citations
19.
Luo, Jialin, Luying Liu, & Yuan Zhu. (2013). Prognostic analysis of 130 patients with nasal and Waldeyer ring NK/T cell lymphoma treated by radiotherapy and/or chemotherapy. Zhonghua fangshe zhongliuxue zazhi. 22(3). 180–184. 2 indexed citations
20.
Meng, Qinghui, Lixin Zhou, Jialin Luo, et al.. (2005). Effect of 7-hydroxystaurosporine on glioblastoma cell invasion and migration1. Acta Pharmacologica Sinica. 26(4). 492–499. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Harris Breakdown of academic impact, for papers by Rong Zheng Breakdown of academic impact, for papers by Patrycja Sosińska Breakdown of academic impact, for papers by Xianwen Zhao Breakdown of academic impact, for papers by Lan Liu Breakdown of academic impact, for papers by Zixuan Yang Breakdown of academic impact, for papers by Lihua Huang
Rankless by CCL
2026